Every year in Europe there are an estimated 400,000 cases of cardiac arrest, equal to one case every thousand people.
Thanks to more the 30 years experience in the sector it has created a device that can reduce mortality even further, ensuring continued oxygenation to the blood. In mid 2020 officially launched on the market ECMOLife.
